Optimal intraoperative management in pancreatic surgery: a systematic review of randomized controlled trials
HPB · 2026-08 · 28 (8) · 1116-1124
DOI: 10.1016/j.hpb.2026.05.003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift HPB, 2026-08. Verfasst von Belkacem Acidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, and Endocrine Surgery, Pitié-Salpêtrière Hospital, AP-HP, Paris, France. Electronic address: Acidi.Belkacem@gmail.co…. Hauptthemen laut MEDLINE: Pancreatectomy, Intraoperative Care. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Despite major advances in pancreatic surgery and reduced mortality, intraoperative management remains poorly standardized and largely dependent on surgeon expertise. This systematic review aimed to synthesise randomized controlled trials evaluating intraoperative surgical techniques in pancreatic surgery and their impact on predefined postoperative outcomes (POPF, DGE, SSI, and length of stay). METHODS: Following PRISMA guidelines, a comprehensive search of PubMed, EMBASE, and the Cochrane Database (2013-2024) identified RCTs assessing intraoperative management in pancreatic surgery. Studies focusing on oncologic outcomes or including fewer than 60 patients were excluded. Quality and risk of bias were assessed using the Jadad Scale and the Cochrane RoB-2 tool. RESULTS: Of 818 articles screened, 47 RCTs met inclusion criteria (Jadad ≥3). Postoperative pancreatic fistula (POPF) was the primary endpoint in 19 studies. Significant POPF reductions were associated with specific techniques such as end-to-side anastomosis, pancreaticogastrostomy, and polyethylene glycol-coated patches. Minimally invasive distal pancreatectomy showed reduced blood loss, hospital stay, and faster recovery. Selective or no-drain policies in distal pancreatectomy were supported by RCTs to reduce clinically relevant POPF. CONCLUSION: Intraoperative management in pancreatic surgery remains heterogeneous. Standardized, evidence-based protocols and additional high-quality RCTs are required to optimize surgical techniques and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General, Visceral, and Endocrine Surgery, Pitié-Salpêtrière Hospital, AP-HP, Paris, France. Electronic address: Acidi.Belkacem@gmail.com.
- Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France; Université of Paris Cité, Paris, France.
- Hepato Biliary Pancreatic and Liver Transplant Surgery, Padova University Hospital, Italy.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of General, Visceral, and Endocrine Surgery, Pitié-Salpêtrière Hospital, AP-HP, Paris, France; Université of Paris Cité, Paris, France.
Zitieren
APA
Acidi, B., Sauvanet, A., Marchegianni, G., Tran Cao, H. S., & Gaujoux, S. (2026). Optimal intraoperative management in pancreatic surgery: a systematic review of randomized controlled trials. HPB, 28(8), 1116-1124. https://doi.org/10.1016/j.hpb.2026.05.003
Vancouver
Acidi B, Sauvanet A, Marchegianni G, Tran Cao HS, Gaujoux S. Optimal intraoperative management in pancreatic surgery: a systematic review of randomized controlled trials. HPB. 2026;28(8):1116-1124. doi:10.1016/j.hpb.2026.05.003
BibTeX
@article{Acidi2026,
author = {Acidi, Belkacem and Sauvanet, Alain and Marchegianni, Giovanni and Tran Cao, Hop S and Gaujoux, Sébastien},
title = {Optimal intraoperative management in pancreatic surgery: a systematic review of randomized controlled trials},
journal = {HPB},
year = {2026},
volume = {28},
number = {8},
pages = {1116--1124},
doi = {10.1016/j.hpb.2026.05.003}
}
EUVIMED